SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to expanded commercial coverage for its fibromyalgia drug, TONMYA, reaching 52 million lives, while the community intensely debates the balance between improving commercial metrics and ongoing concerns regarding potential stock dilution. Investors are actively tracking prescription script growth as a key indicator of commercial adoption.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing high volatility as investors rotate into the data center and AI power infrastructure trade, focusing on the company's expanding project pipeline. Community discussion is sharply divided between bullish expectations for potential hyperscaler contracts and skepticism driven by the firm's historical performance, dilution, and lack of immediate profitable execution.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors react to the company's multi-year agreement to provide AI compute infrastructure, a move that signals its transition toward becoming a significant independent cloud and AI player. The community is actively debating the stock's massive short interest and the strategic value of the Northern Data acquisition, with many focused on the long-term potential of Rumble's growing GPU footprint despite recent volatility.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Nurix Therapeutics is gaining attention as investors react to positive clinical data for its blood cancer drug bexobrutideg, which targets a significant market opportunity and positions the company for potential long-term value. Community members are actively discussing the possibility of a buyout by major pharmaceutical players and evaluating the company's strong cash position and pipeline potential against existing competitive headwinds.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning, Inc. is surging following a landmark multi-year partnership with Nvidia to significantly expand U.S. manufacturing capacity for optical connectivity and fiber-optic infrastructure required for AI data centers. Investors and community members are actively discussing the stock's role as a critical 'picks and shovels' play, with many noting that the company's glass and fiber technologies are essential for the horizontal scaling of modern AI infrastructure.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following the announcement of a 550 million dollar credit facility, a move that the community interprets as a major catalyst for funding rapid AI data center expansion. Investors are highly engaged in debates regarding the company's valuation compared to sector peers and are closely tracking imminent project pipelines and hyperscaler lease activity.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang is trending due to anticipation surrounding its upcoming earnings report and growing momentum in the low-altitude economy sector, driven by recent commercial flight milestones in global markets like Thailand and Qatar. Community discussion remains polarized, with many investors highlighting the stock's significant long-term potential as a certified first-mover, while others express frustration over stagnant price action and regulatory delivery timelines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly shares are surging as positive Phase 3 clinical trial results for its triple-agonist obesity drug, retatrutide, confirm best-in-class efficacy for weight loss and cardiometabolic health. The community is actively discussing the drug's potential to set a new benchmark in the weight-loss market, even as investors weigh the balance between record-breaking trial data and the long-term competitive dynamics within the GLP-1 sector.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup is seeing increased volatility as investors weigh lingering concerns over sector-wide consumer demand and tariff-related margin pressures against the company's defensive appeal and high dividend yield. Market sentiment remains split, with some traders actively betting on a potential rebound driven by institutional accumulation, while others express caution regarding elevated debt levels and broader headwinds facing the packaged food industry.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is generating significant community excitement and price appreciation driven by expectations surrounding near-term regulatory catalysts, including an anticipated U.S. patent term extension and potential European approval for its lead drug, Miplyffa. Investors are actively discussing the stock's strong balance sheet and potential M&A prospects, weighing these fundamental strengths against management's history of volatility and the upcoming earnings release.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$amrn last one fellas, here’s the adverse events, the mild gastrointestinal bleeding in four patients, he mentioned which we expected to see some of and even the interviewer noded without excitement. It was understandable, I didn’t hear feel any overreaction to any of these.

Jeff

morisboris

jblood83

Brad

Ben J

draghinibal

Who_is_JohnnyGalt

Semis_Grouchnix

Mark Brady

Anil

Abc Def

Bruce Lee

Marcus

StockTwits for iOS

Amarin Corp - ADR

 last one fellas, here’s the adverse events, the mild gastrointestinal bleeding in four patients, he mentioned which we expected to see some of and even the interviewer noded without excitement. It was understandable, I didn’t hear feel any overreaction to any of these.

Steve Gibson

@Sggibson86 Awesome!  Appreciate your dedication and posts.  Thank you!

StockTwits Web

 Awesome!  Appreciate your dedication and posts.  Thank you!

@Sggibson86 I&#39;m impressed! You did well tracking

louieblouie

@Sggibson86 ; actually in line with what all investors experience so users and investors experience the same thing. That’s a positive!

 ; actually in line with what all investors experience so users and investors experience the same thing. That’s a positive!

Dr. Doom

@Sggibson86 Two questions:
1.) Were these only hospitalized patients? 
2.) Did he mention if all of the patients in both arms were on prophylactic anticoagulation during that time with either heparin or lovenox? 

Thanks for posting!! 👍🏼

 Two questions:
1.) Were these only hospitalized patients? 
2.) Did he mention if all of the patients in both arms were on prophylactic anticoagulation during that time with either heparin or lovenox? 

Thanks for posting!! 👍🏼

@Sggibson86 much appreciated. It&#39;s very promising as a therapeutic.

Sweaty Tricks

 much appreciated. It's very promising as a therapeutic.

@Who_is_JohnnyGalt 1) 100, symptomized, covid positive, out patients were randomized. I’m sorry I don’t know 2).

 1) 100, symptomized, covid positive, out patients were randomized. I’m sorry I don’t know 2).